Depression and Anxiety Trial, Recruiting NCT03678194 Sponsor: Centre Hospitalier Charles Perrens, Bordeaux Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT03678194
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 65 years
  • People who have been diagnosed with depression based on a formal structured clinical interview using standard diagnostic criteria (DSM-IV)
  • People who started taking antidepressant medication less than 5 days before joining the trial
  • People who are being treated as an outpatient (not staying overnight in hospital)
  • People who have been told their diagnosis by their doctor
  • People who have been fully informed about the trial and have signed a written consent form

Who may not be able to join:

  • People who currently have another mental health condition (such as schizophrenia or bipolar disorder) that requires psychiatric medication or a stay in a psychiatric ward
  • People who have a past history of psychosis, schizophrenia, bipolar I or II disorder, or depression with psychotic features
  • People who have a cognitive difficulty that would prevent them from understanding the consent process or how the study works
  • People who have a physical, cognitive, or other condition that would prevent them from using the study device — for example, deafness, significant vision impairment, or being unable to read
  • People who do not understand the French language

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33(0)556563449

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Charles Perrens, Bordeaux
Registry
ClinicalTrials.gov
Start date
14 October 2020
Est. completion
31 December 2024

Where this trial is recruiting

🇫🇷 France

Primary endpoints

A greater clinical response in the active group (smartphone application) comparatively to the comparator group (clinical response was defined as a decline in HDRS-17 score greater than 50%)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov